HUP0101725A2 - Eljárás az 1-(4-hidroxi-fenil)-2-(4-hidroxi-4-fenil-piperidin-1-il)-1-propanol-mezilátsó trihidrátjának előállítására, és az erre szolgáló intermedierek - Google Patents

Eljárás az 1-(4-hidroxi-fenil)-2-(4-hidroxi-4-fenil-piperidin-1-il)-1-propanol-mezilátsó trihidrátjának előállítására, és az erre szolgáló intermedierek

Info

Publication number
HUP0101725A2
HUP0101725A2 HU0101725A HUP0101725A HUP0101725A2 HU P0101725 A2 HUP0101725 A2 HU P0101725A2 HU 0101725 A HU0101725 A HU 0101725A HU P0101725 A HUP0101725 A HU P0101725A HU P0101725 A2 HUP0101725 A2 HU P0101725A2
Authority
HU
Hungary
Prior art keywords
hydroxy
trihidrate
phenylpiperidin
mesylate
propanol
Prior art date
Application number
HU0101725A
Other languages
English (en)
Inventor
Joseph Philip Rainville
Terry Gene Sinay
Stanley Walter Walinsky
Original Assignee
Pfizer Products Inc.
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Pfizer Products Inc. filed Critical Pfizer Products Inc.
Publication of HU0101725D0 publication Critical patent/HU0101725D0/hu
Publication of HUP0101725A2 publication Critical patent/HUP0101725A2/hu
Publication of HUP0101725A3 publication Critical patent/HUP0101725A3/hu

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D211/00—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings
    • C07D211/04—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom
    • C07D211/06—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members
    • C07D211/08—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members with hydrocarbon or substituted hydrocarbon radicals directly attached to ring carbon atoms
    • C07D211/18—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members with hydrocarbon or substituted hydrocarbon radicals directly attached to ring carbon atoms with substituted hydrocarbon radicals attached to ring carbon atoms
    • C07D211/20—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members with hydrocarbon or substituted hydrocarbon radicals directly attached to ring carbon atoms with substituted hydrocarbon radicals attached to ring carbon atoms with hydrocarbon radicals, substituted by singly bound oxygen or sulphur atoms
    • C07D211/22—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members with hydrocarbon or substituted hydrocarbon radicals directly attached to ring carbon atoms with substituted hydrocarbon radicals attached to ring carbon atoms with hydrocarbon radicals, substituted by singly bound oxygen or sulphur atoms by oxygen atoms
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D211/00—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings
    • C07D211/04—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom
    • C07D211/06—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members
    • C07D211/36—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D211/40—Oxygen atoms
    • C07D211/44—Oxygen atoms attached in position 4
    • C07D211/52—Oxygen atoms attached in position 4 having an aryl radical as the second substituent in position 4
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y02—TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
    • Y02P—CLIMATE CHANGE MITIGATION TECHNOLOGIES IN THE PRODUCTION OR PROCESSING OF GOODS
    • Y02P20/00—Technologies relating to chemical industry
    • Y02P20/50—Improvements relating to the production of bulk chemicals
    • Y02P20/55—Design of synthesis routes, e.g. reducing the use of auxiliary or protecting groups

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Neurosurgery (AREA)
  • Biomedical Technology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Neurology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Hydrogenated Pyridines (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Low-Molecular Organic Synthesis Reactions Using Catalysts (AREA)
HU0101725A 2000-04-28 2001-04-27 Process for the preparation of the mesylate trihidrate of 1-(4-hydroxy-phenyl)-2-(4-hydroxy-4-phenylpiperidin-1-yl)-1-propanol and intermediates useful therefor HUP0101725A3 (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US20041700P 2000-04-28 2000-04-28

Publications (3)

Publication Number Publication Date
HU0101725D0 HU0101725D0 (en) 2001-07-30
HUP0101725A2 true HUP0101725A2 (hu) 2002-02-28
HUP0101725A3 HUP0101725A3 (en) 2003-04-28

Family

ID=22741639

Family Applications (1)

Application Number Title Priority Date Filing Date
HU0101725A HUP0101725A3 (en) 2000-04-28 2001-04-27 Process for the preparation of the mesylate trihidrate of 1-(4-hydroxy-phenyl)-2-(4-hydroxy-4-phenylpiperidin-1-yl)-1-propanol and intermediates useful therefor

Country Status (26)

Country Link
US (1) US6570018B2 (hu)
EP (1) EP1149831B1 (hu)
JP (1) JP2001354650A (hu)
KR (1) KR100432841B1 (hu)
CN (1) CN1211366C (hu)
AR (1) AR028377A1 (hu)
AT (1) ATE275130T1 (hu)
AU (1) AU781715B2 (hu)
BR (1) BR0101611A (hu)
CA (1) CA2345286C (hu)
CZ (1) CZ20011472A3 (hu)
DE (1) DE60105221T2 (hu)
DK (1) DK1149831T3 (hu)
ES (1) ES2225425T3 (hu)
HK (1) HK1040514B (hu)
HU (1) HUP0101725A3 (hu)
ID (1) ID30012A (hu)
IL (1) IL142706A0 (hu)
IN (1) IN191534B (hu)
PL (1) PL347299A1 (hu)
PT (1) PT1149831E (hu)
RU (1) RU2192415C1 (hu)
SI (1) SI1149831T1 (hu)
TW (1) TWI222440B (hu)
YU (1) YU27801A (hu)
ZA (1) ZA200103321B (hu)

Families Citing this family (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6743921B2 (en) * 2002-01-24 2004-06-01 Dsm Catalytica Pharmaceuticals, Inc. Process for the preparation of nonracemic syn-1-(4-hydroxy-phenyl)-2-(4-hydroxy-4-phenyl-piperidin-1-yl)-1-propanol compounds
CN105037221B (zh) * 2015-06-18 2017-05-10 吉林大学珠海学院 一种具有神经保护作用的化合物及其制备方法

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
UA59341C2 (uk) 1995-08-11 2003-09-15 Пфайзер, Інк. (1s,2s)-1-(4-гідроксифеніл)-2-(4-гідрокси-4-фенілпіперидин-1-іл)-1-пропанолметансульфонат тригідрат
TW450807B (en) * 1995-09-15 2001-08-21 Pfizer Pharmaceutical compositions for treating tinnitus comprising neuroprotective agents

Also Published As

Publication number Publication date
CZ20011472A3 (cs) 2001-12-12
EP1149831A1 (en) 2001-10-31
HUP0101725A3 (en) 2003-04-28
DE60105221T2 (de) 2005-09-15
AU781715B2 (en) 2005-06-09
YU27801A (sh) 2003-04-30
CA2345286A1 (en) 2001-10-28
KR100432841B1 (ko) 2004-05-24
US6570018B2 (en) 2003-05-27
EP1149831B1 (en) 2004-09-01
DK1149831T3 (da) 2004-12-06
PL347299A1 (en) 2001-11-05
AU3889701A (en) 2001-12-13
CN1322716A (zh) 2001-11-21
ID30012A (id) 2001-11-01
CN1211366C (zh) 2005-07-20
ATE275130T1 (de) 2004-09-15
PT1149831E (pt) 2004-11-30
JP2001354650A (ja) 2001-12-25
HK1040514A1 (en) 2002-06-14
KR20010098924A (ko) 2001-11-08
RU2192415C1 (ru) 2002-11-10
CA2345286C (en) 2004-11-09
BR0101611A (pt) 2002-01-15
ES2225425T3 (es) 2005-03-16
AR028377A1 (es) 2003-05-07
SI1149831T1 (en) 2005-02-28
IL142706A0 (en) 2002-03-10
TWI222440B (en) 2004-10-21
HK1040514B (zh) 2005-10-28
HU0101725D0 (en) 2001-07-30
US20020016466A1 (en) 2002-02-07
ZA200103321B (en) 2002-10-24
DE60105221D1 (de) 2004-10-07
IN191534B (hu) 2003-12-06

Similar Documents

Publication Publication Date Title
AU2002346641A8 (en) Apertured non-woven composites and method for making
EG21886A (en) Disposable wipe-out sheet and process for making the same
AU4468201A (en) External preparation for the skin and beautifying agents
HK1117188A1 (en) Adhesive agent for connecting electrode and connecting method using the adhesive agent
IL158693A0 (en) Azole compounds, process for preparation of the same and use thereof
EG22654A (en) Disposable wipe-out sheet and process for making the same
IL175983A0 (en) Processes and intermediates for the preparation of (r) -??-(2,3 - dimethoxyphenyl) - 1 - [2 - (4-fluorophenyl) ethyl] - 4 - piperidine methanol
HUP0300700A3 (en) Method for permanently shaping keratin fibres, and agents
HUP0101725A3 (en) Process for the preparation of the mesylate trihidrate of 1-(4-hydroxy-phenyl)-2-(4-hydroxy-4-phenylpiperidin-1-yl)-1-propanol and intermediates useful therefor
ZA200106928B (en) Protection of keratinous fibers using ceramides and/or glycoceramides.
HUP0104797A3 (en) Method for preparing 4-(3-pyridinyl)-1h-imidazole and the intermediates used
HUP0101723A3 (en) Process for the preparation of the meylate salt trihydrate of 1-(4-hydroxyphenyl)-2-(4-hydroxy-4-phenylpiperidin-1-yl)-1-propanol and intermediates useful therefor
EP1328801A4 (en) ACOUSTIC INTERFEROMETRY METHOD AND DEVICE
EP1171051A4 (en) DEVICE AND METHOD FOR TREATING SOLID MATERIALS, SUCH AS HARD TISSUES
HUP0004503A3 (en) Process for the preparation of paroxetine hydrochloride
HUP0105386A2 (hu) Eljárás és berendezés faanyag telítésére
AU2002348942A8 (en) Process for the preparation of tofisopam and new intermediates
HUP0004052A3 (en) Improved process for the preparation of 1-(3-chloro-phenyl)-2-bromo-propane-1-one
EP1453999A4 (en) CELLULOSE-BASED CORE FIBER WITH BRAIN-SURFACE MASERING AND CORRESPONDING COMPOSITES AND USES
AU2002232017A1 (en) Process of preparing paroxetine and intermediates for use therein
HUP0202145A3 (en) The use of r(+)-alpha-(2,3-dimethoxyphenyl)-1-[2-(4-fluorophenyl)ethyl]-4-piperidinemethanol for the treatment of sleep disorders
TW530737U (en) Apparatus for indicating the planning and cutting thickness of wood planning machine
GB0125119D0 (en) Process of preparing paroxetine and intermediates for use therein
TW481088U (en) Assembly structure for brush anvil of splitting and cutting roller
HUP0302407A3 (en) New method of preparation of (s)-n-tert-butyl-1,2,3,4-tetrahydroisoquinoline-3-carboxamide and the intermediates

Legal Events

Date Code Title Description
FD9A Lapse of provisional protection due to non-payment of fees